Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of metastatic renal cell carcinoma (SWITCH-II)

Titel:: Phase III randomized, sequential, open-label study to evaluate the efficacy and safety of sorafenib-pazopanib versus pazopanib-sorafenib in the treatment of metastatic renal cell carcinoma (SWITCH-II)
Dokumenttyp:: Meeting Abstract
Autor(en):: Retz, M; Bedke, J; Herrmann, E; Grimm, MO; Zimmermann, U; Müller, L; Leiber, C; Teber, D; Wirth, M; Bolenz, C; van Alphen, R; De Santis, M; Beeker, A; Frank, M; Gschwend, JE
Zeitschriftentitel:: Ann Oncol
Jahr:: 2017
Band / Volume:: 28 5
Seitenangaben Beitrag:: -
Sprache:: eng
Print-ISSN:: 0923-7534
TUM Einrichtung:: Urologische Klinik und Poliklinik
BibTeX

Vorkommen: